NRO Neurones SA

NEURONES: Net profit (group share) up 11.5% in 2023

NEURONES: Net profit (group share) up 11.5% in 2023

PRESS INFORMATION

Heading: 2023 annual results        Nanterre, March 6, 2024 (after trading)

Net profit (group share) up 11.5% in 2023

Financial statements at December 31 (1)20222023
Revenues665.4741.2
Business operating profit (2)77 (11.6%)81.5 (11%)
Operating profit72.9 (11%)75.9 (10.2%)
Financial profit04.9
Tax on earnings(21.1)(22.2)
Net profit51.8 (7.8%)58.6 (7.9%)
- of which, group share44.349.4
Free cash flow (3)37.651.6
Cash and cash equivalents (net of financial debt) (4)271.8290.4
Staff at year-end6,4066,749

(1)        In millions of euros, 2023 financial statements approved by the Board of Directors on March 6, 2024.

(2)        Before cost of bonus shares.

(3)        Cash flow from operational activities, plus financial profit and less net industrial investments.

(4)        Excluding IFRS16 lease liabilities.

Achievements

NEURONES once again achieved double-digit growth in 2023 (+11.4%, of which +11.1% organic), while net income stood at 7.9% of revenues (7.8% in 2022).

Free cash flow rose sharply, thanks to a virtually stable working capital requirement, even after significant investment in the new SecNumCloud sovereign and secure cloud platform. Capex amounted to €17.9 million (previous year: €10.6 million).

Cash and cash equivalents at the end of the year stood at €290.4 million (€12 per share).

Outlook

As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues (on May 15, after trading). Driven by solid underlying trends (cloud and digital), NEURONES is well positioned to achieve another year of profitable growth.

At the Shareholders' Meeting on June 6, the Board will suggest paying a dividend of €1.2 per share for 2023.

About NEURONES

With over 6,800 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – SRD (deferred settlement) mid-caps



Press Relations:

O'Connection

Valérie Hackenheimer

Tel.: +33 (0)6 12 80 35 20









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37



Attachment



EN
06/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025 PRESS INFORMATIONHeading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd quarter revenues211.3225+ 6.5%+ 6.2%Annual revenues810.4857.2+ 5.8%+ 5.1% Achievements NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations. Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend. With its decentralized and responsive structu...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique en 2025

NEURONES : + 5,1% de croissance organique en 2025 INFORMATION PRESSERubrique : C.A. annuel 2025        Nanterre, le 11 février 2026 (après Bourse) + 5,1% de croissance organique en 2025 (en cours d’audit, en M€)20242025Croissancedont organiqueChiffre d’affaires 4e trimestre211,3225+ 6,5%+ 6,2%Chiffre d’affaires annuel810,4    857,2+ 5,8%+ 5,1% Réalisations NEURONES clôture l’exercice avec un chiffre d’affaires annuel de 857,2 M€, dépassant ainsi ses anticipations. La croissance est portée par les projets digitaux et data (progression à deux chiffres), tandis que les activités liées à l’I...

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch